Canine cutaneous epitheliotropic T-cell lymphoma (CETL) is associated with a poor prognosis and without consistently beneficial treatment options. This case report describes a 9-year-old Staffordshire bull terrier with CETL treated with oclacitinib (0.7 mg/kg twice daily), resulting in partial remission that was maintained for three months. Further studies are warranted.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/vde.12976 | DOI Listing |
Publication Analysis
Top Keywords
canine cutaneous
8
cutaneous epitheliotropic
8
epitheliotropic t-cell
8
t-cell lymphoma
8
case report
8
treatment canine
4
lymphoma oclacitinib
4
oclacitinib case
4
report canine
4
lymphoma cetl
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!